Benefit of rapid on-site evaluation (ROSE) on diagnostic accuracy of endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) has never been evaluated in a randomized study. This trial aimed to test the hypothesis that in solid pancreatic lesions (SPLs), diagnostic accuracy of EUS-FNB without ROSE was not inferior to that of EUS-FNB with ROSE.
Endoscopic Ultrasound–guided Fine-needle Biopsy With or Without Rapid On-site Evaluation for Diagnosis of Solid Pancreatic Lesions: A Randomized Controlled Non-Inferiority Trial
Crinò, Stefano Francesco
;Manfrin, Erminia;Bernardoni, Laura;Gabbrielli, Armando;Locatelli, Francesca;Scarpa, Aldo;
2021-01-01
Abstract
Benefit of rapid on-site evaluation (ROSE) on diagnostic accuracy of endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) has never been evaluated in a randomized study. This trial aimed to test the hypothesis that in solid pancreatic lesions (SPLs), diagnostic accuracy of EUS-FNB without ROSE was not inferior to that of EUS-FNB with ROSE.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Gastroenterology 2021.pdf
solo utenti autorizzati
Tipologia:
Versione dell'editore
Licenza:
Copyright dell'editore
Dimensione
778.24 kB
Formato
Adobe PDF
|
778.24 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
